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Three Severe Cases of EBS Dowling-Meara Caused by
Missense and Frameshift Mutations in the Keratin 14
Gene
Matthias Titeux1,2, Juliette Mazereeuw-Hautier1,2,3, Smaı¨l Hadj-Rabia4, Catherine Prost5, Laure Tonasso1,2,
Sylvie Fraitag6, Yves de Prost4, Alain Hovnanian1,2,7 and Christine Bodemer4
We report three unrelated patients affected at birth with an unusually severe form of epidermolysis bullosa
simplex Dowling-Meara type (EBS-DM) because of mutations in KRT14 encoding keratin 14. Two patients were
heterozygous for the previously described p.M119T mutation. The third patient was heterozygous for a novel
c.1246delC mutation predicting the replacement of the helix termination peptide and the tail domain by a 25
amino-acid aberrant carboxyterminal sequence. At age 2 years, patients carrying the p.M119T mutation still
suffered from severe EBS-DM, whereas the patient harboring the c.1246delC mutation has improved over time.
These cases illustrate genotype–phenotype correlations and have implications for genetic counselling of EBS.
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INTRODUCTION
Epidermolysis bullosa simplex (EBS) comprises a group of
inherited skin diseases characterized by intraepidermal
blistering upon mild trauma. In the most severe type, EBS
Dowling-Meara (EBS-DM) blistering occurs in clusters and
can be generalized. The Koebner type shows milder general-
ized blistering, whereas in the mildest form, EBS Weber-
Cockayne, blistering is confined to hands and feet. The
disease is caused by mutations in either the KRT5 or the
KRT14 gene encoding keratin 5 and keratin 14 (K14),
respectively. We report three cases of unusually severe EBS-
DM caused by mutations in KRT14. The probands presented
with particular severity during the neonate period. Two
patients harbored a recurrent K14 missense mutation in the
helix initiation peptide, whereas the third patient carried a
new K14 mutation predicting the replacement of the helix
termination peptide and the entire tail domain of the K14
protein by an aberrant amino-acid sequence.
RESULTS
Case reports
The three children were Caucasian with healthy non-
consanguineous parents. Their neonatal period was char-
acterized, since the first days of life, by a poor general
condition with large tense blisters associated with extensive
skin erosions and difficultiy to thrive. Skin lesions were
generalized but more pronounced on extremities (Figure
1a–c). Oral mucosal involvement was noted. There were no
milia or scar. Acute phases of spontaneous blistering were
observed since the first weeks of life, sometimes preceded by
inflammatory plaques and associated with severe pruritus
(patient 1). Blisters had a herpetiform aspect and could be
hemorrhagic. In patients 1 and 2, a marked painful
palmoplantar keratoderma appeared during the first weeks
of life (Figure 1d–h). Progressive functional impairment and
flexural deformity resulted from early and impressive nail
thickening in these two neonates and onychogryphosis in
patient 2 (Figure 1d and f). In patient 3, mild focal and painful
plantar keratoderma developed at blister sites during the first
year of life (Figure 1i). The severity of blistering and
keratoderma required daily dressings performed under
general anaesthesia. In the three patients, recurrent skin
infections (Staphylococcus aureus and Pseudomonas aerugi-
nosa), septicemia (S. aureus, P. aeruginosa, Enteroccocus
cloacae) were observed. In patient 2, nasogastric feeding was
necessary from 2 to 7 months of age. The patients are now
aged 1 (patient 1), and 2 years (patients 2 and 3). They have
been hospitalized from birth until the age of 7 months
(patients 1 and 2), and from birth until the second month of
life (patient 3). Skin fragility and blistering remain extensive
and require constant protective measures. Blistering is
exacerbated by high environmental temperatures. Standing
posture is still not acquired in patient 1, with persistent,
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severe keratoderma, thick pachyonychia, and flexural retrac-
tions limiting mobility of the fingers (Figure 1d). In patient 2,
palmoplantar keratoderma predominant on the feet (Figure
1f–h), worsening nail dystrophy and flexion deformity led to
impaired function (Figure 1f and h), and the boy is still not
walking at the age of 2 years. In patient 3, the disease is now
less severe: keratoderma remains moderate, blistering is less
extensive, occurring essentially on frictions areas, but
frequent episodes of palmoplantar hemorrhagic blisters
(Figure 1j), herpetiform lesions on the trunk, and mucosal
lesions occur. Cutaneous infections remain frequent.
Mutation analysis
Sequence analysis KRT14 exon 1 revealed a T4C base
substitution at nucleotide 416 in patients 1 and 2 (Figure 2a),
resulting in the replacement of methionine (ATG) by
threonine (ACG) at codon 119 (p.M119T) in the helix
initiation peptide of K14. In addition, a T4C substitution at
nucleotide 429 resulting in a silent polymorphism was
identified in patient 2. In patient 3, sequence analysis
KRT14 exon 6 revealed the deletion of a C1246 (Figure 2a)
leading to a frameshift and a premature termination codon 26
codons downstream, hence denoted p.R416AfsX26. The
mutated protein, lacking the helix termination peptide and
the tail domain, has a lower predicted molecular weight of
47.9 kDa relative to the wild-type molecule (51.5 kDa) and
contains a 25-residue long missense carboxy-terminal se-
quence: AACWRARTPTSPPPSSPLDRSHPEM (Figure 2b). This
sequence does not correspond to a known protein motif.
Sequencing of the entire KRT14 and KRT5 genes in the three
patients showed no additional mutations or polymorphisms.
Screening of the patients’ parents failed to detect the
mutations suggesting that all three patients are affected with
de novo mutations. However, germline mosaicism in the
parents cannot be excluded.
The p.M119T K14 mutant aggregates in cultured keratinocytes
under stress conditions
K14 expression was studied by immunocytochemistry on
cultured EBS keratinocytes from patient 2 and normal human
keratinocytes, under normal culture conditions and after
hypo-osmotic shock. In mutant cells, hypo-osmotic shock
induces rapid changes in the configuration of intermediate
filaments (D’Alessandro et al., 2002). Under normal culture
conditions, no aggregates could be seen in normal and EBS
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Figure 1. Clinical appearance of (a) patient 1 at 1 year of age, (b) patient 2 at two years of age, and (c) patient 3 at two years of age. Generalized, herpetiform,
hemorrhagic skin blistering occurs mainly on the extremities. (d and e) Close-up views of patient 1 showing the severity of skin blistering and marked
keratoderma leading to flexural retractions with limited mobility of the fingers. (d) Nail thickening and onychogryphosis are also observed. (f–h) Close-up views
of patient 2 showing marked palmo-plantar hyperkeratosis (f, g) and nail thickening (h). (i, j) Hands of patient 3 showing hemorrhagic blistering and mild
hyperkeratosis.
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Figure 2. (a) Chromatograms of KRT14 gene show the heterozygous T4C
change at nucleotide 416 identified in patients 1 and 2, and the
heterozygous deletion of a cytosine at position 1246 in patient 3.
(b) Diagrammatic representation of K14 cDNA showing the positions of the
two mutations c.416T4C (p.M119T) and c.1246delC (p.R416AfsX26).
Corresponding protein domains are indicated in black. The red star indicates
the position of the p.M119T mutation on the protein. The red wavy line
represents the aberrant tail in the p.R416AfsX26 mutant.
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keratinocytes (data not shown). However, following hypo-
osmotic shock, while no aggregates of K14 filaments were
present in normal human keratinocytes (Figure 3a), numerous
aggregates were detected in EBS keratinocytes (Figure 3b and
c). Unfortunately, cells from patients 1 and 3 were not
available for this analysis.
Electron microscopy analysis
Electron microscopy analysis of the skin sample from patient
1 (Figure 4a) revealed a deep cleavage within the cytoplasm
of basal keratinocytes with no detectable aggregates of
tonofilaments. Hemidesmosomes were normal. In patient 3,
the cleavage occurred either beneath the nucleus or near the
basal end of basal keratinocytes (Figure 4b). Rare and small
tonofilament aggregates were present (data not shown). In the
peribullous area, keratinocytes showed a clarified cytoplasm
and rupture of tonofilaments near their insertion on hemi-
desmosomes which were normal elsewhere. For technical
reasons, no electron microscopy analysis could be performed
on the skin sample from patient 2.
DISCUSSION
EBS-DM is the most severe form of EBS and can be life-
threatening in neonates. Improvement usually occurs during
middle to late childhood and blistering may be minimal in
adult life, whereas palmo-plantar keratoderma may become
the major complaint of adult patients. Nevertheless, cases of
severe EBS-DM because of mutations in K14, such as
p.M119T (Shemanko et al., 1998; Cummins et al., 2001)
and p.Y129D (Chan et al., 1996) have been described with
extreme severe lesions at birth associated with poor
improvement with age. The clinical features of these patients
and of the patients described herein are very similar. Another
frequent but inconstant feature of EBS-DM is the presence of
electron-dense aggregates of K5/K14 keratin filaments in the
cytoplasm of basal keratinocytes (Ishida-Yamamoto et al.,
1991).
The p.M119T mutation
The p.M119T mutation was previously described in three
reports (Shemanko et al., 1998; Cummins et al., 2001;
Pfendner et al., 2005). All patients showed remarkably similar
clinical features. At 41 years old, the patient described by
Shemanko et al. (1998) still suffered from gross palmoplantar
hyperkeratosis resulting in flexion contracture of the hands
and considerable functional difficulty. An interesting point
is the early onset and severe hyperkeratosis associated with
the p.M119T mutation. Although hyperkeratosis is a
common characteristic of EBS-DM, it is usually less severe
and develops at a later age than in the patients with the
p.M119T mutation (Shemanko et al., 1998). Although
Shemanko et al. (1998) proposed that the particularly severe
hyperkeratosis in their patient might be because of effects of
modifying genes, we provide evidence that this phenotype is
likely to be a direct consequence of the mutation. Strikingly,
whereas all the reported cases harboring this mutation are
affected with a severe form of EBS-DM associated with
marked hyperkeratosis, keratin aggregates are not always
present. Shemanko et al. (1998). showed large aggregates of
tonofilaments beneath the nucleus, whereas Cummins et al.
(2001) found no such aggregates in basal keratinocytes.
Similar differences were observed in EBS-DM patients
harboring the N176S mutation in KRT5 (Stephens et al.,
1997; Sorensen et al., 1999). We describe here two different
cases in which keratin aggregates could not be detected
by electronic microscopy of skin samples, but were seen
in cultured keratinocytes of patient 2. Thus, it seems
that tonofilament clumping is not necessarily associated with
EBS-DM.
The c.1246delC mutation (p.R416AfsX26)
Mutation c.1246delC leads to a frameshift from codon 416,
encoding the first arginine of the YRRLLEGE sequence (helix
termination peptide), creating a 25-amino-acid long missense
sequence. The mutant protein lacks the R/KLLEGE motif as
well as the entire tail sequence of K14. Although the roles of
the head and tail domains of intermediate filaments are not
completely elucidated, studies indicate that these domains
may influence filament–filament interactions and filament
stability (Bousquet et al., 2001). Gu et al. (2002) have
described a case of EBS-Koebner type because of mutation
E411X in K14 generating a truncated protein missing the helix
termination peptide and the entire tail domain. At 31 years of
age, the patient still suffers from generalized blistering in
response to minor mechanical trauma but does not exhibit
palmo-plantar hyperkeratosis nor scarring. The main differ-
ence between the E411X tailless mutant and p.R416AfsX26
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Figure 3. Detection of keratin filament aggregates. K14 is detected using a
monoclonal antibody in normal human keratinocytes (a) and in keratinocytes
from patient 2 (b, c). Following hypo-osmotic shock in vitro, mutant
keratinocytes show numerous keratin aggregates (arrowheads), whereas no
clumps of K14 are detected in normal human keratinocytes (a).
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Figure 4. Electronic microscopy analysis. (a) Patient 1 skin section. A deep
cleavage (%) is observed within basal keratinocytes leaving a thin portion of
the cytoplasm on the floor of the cleft. No tonofilament clumping could be
seen. Scale bar¼ 2.6 mm. (b) Analysis of the skin biopsy from patient 3 reveals
a clarification in the deepest part of the basal keratinocyte cytoplasm (%) and
tonofilament (tf) disruption close to the inner plaque of hemidesmosomes.
Bar¼1.4 mm. HD¼ hemidesmosomes, LD¼ lamina densa, De¼ dermis.
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K14 is the presence of the aberrant tail domain. It is not clear
whether this aberrant tail or the difference in the position of
the mutation along the K14 protein could account for the
difference in the observed severity. Patients 1 and 2 still suffer
from a particularly severe form of EBS-DM with persistent,
extensive spontaneous blistering and unusually marked
hyperkeratosis resulting in poor functional prognosis. In
contrast, patient 3 has developed less frequent lesions after
a severe and difficult neonate period. Our report illustrates
the extreme severity of some instances of EBS at birth, the
difficulties in the management of their complications, and the
variability observed in the evolution of the disease. This
should be taken into consideration for genetic counselling.
MATERIALS AND METHODS
Informed consent was obtained from the patients’ parents. This study
was approved by the medical ethical committees of the Purpan
Hospital, Toulouse and Necker Hospital, Paris. The study was
conducted according to the Declaration of Helsinki Principles.
Mutation detection
Genomic DNA was extracted from peripheral blood leukocytes
using standard methods. The KRT14 gene was sequenced using nine
overlapping PCR products. The exon 1 mutation was detected using
primers: forward, TCTCATCCTCCCGCTTCTC, and reverse, AAGG
GATCTGGGGTGGACT. The exon 6 mutation was detected using
primers: forward, TCCGGCGCACCATGCAGA, and reverse,
GGGAGGAGGAGAGGCTGT. KRT5 was sequenced using 11 over-
lapping PCR products. These were purified using the Promega
Wizard PCR kit (Promega, Charbonnie`res, France). Cycle sequencing
reactions were performed using the ABI Big Dye terminator 3.1 on an
ABI 3100 DNA sequencer (ABI, Foster city, CA). Sequences were
compared to KRT14 (GenBank accession number NM_000526) and
KRT5 (GenBank accession number NM_000424.2) cDNA reference
sequences.
Cell culture and osmotic shock
Keratinocytes were cultured from a 5-mm biopsy obtained from
patient 2, as described by Rheinwald and Green (1975). Osmotic
shock was performed as described in D’Alessandro et al. (2002).
Subsequently, cells were fixed for 20 minutes in methanol at 201C.
Immunocytochemistry
Immunocytochemistry was performed on methanol-fixed cells. The
primary antibody was a mouse monoclonal antibody against the
C-terminus domain of human K14 (LL002, 1:50, Novocastra,
Norwell, MA). The secondary antibody was a rabbit anti-mouse
IgG FITC conjugated (1:40, Dako, Trappes, France).
Electron microscopy
Four millimeter punch biopsies from lesional skin of patients 1 and 3
were fixed in 2.5% glutaraldehyde, post-fixed in 1% osmium-
tetroxyde, dehydrated in a graded ethanol series and embedded in
Epon 812. Semithin sections (1mm) were stained with toluidin blue.
Ultrathin sections were selected, contrasted with uranyl acetate and
lead citrate and examined with a Philips CM 10 transmission
electron microscope.
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